Bantings Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.60 M
as on 16-12-2024
- Company Age 17 Year, 8 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.85 M
as on 16-12-2024
- Revenue -0.44%
(FY 2020)
- Profit -10509.54%
(FY 2020)
- Ebitda -127.20%
(FY 2020)
- Net Worth -77.54%
(FY 2020)
- Total Assets 7.59%
(FY 2020)
About Bantings Pharmaceuticals
The Corporate was formerly known as Oxford Marketing Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹5.85 M.
Ritwik Mukherjee, Prativa Mukherjee, and Samapika Mukherjee serve as directors at the Company.
- CIN/LLPIN
U24232WB2007PTC121115
- Company No.
121115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Bardhaman, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bantings Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritwik Mukherjee  | Managing Director | 19-Dec-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prativa Mukherjee | Director | 19-Dec-2007 | Current |
| Samapika Mukherjee | Director | 19-Dec-2007 | Current |
Financial Performance of Bantings Pharmaceuticals.
Bantings Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.44% decrease. The company also saw a substantial fall in profitability, with a 10509.54% decrease in profit. The company's net worth observed a substantial decline by a decrease of 77.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bantings Pharmaceuticals?
In 2020, Bantings Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Asansol Medical Centre Pvt LtdActive 38 years 3 monthsRitwik Mukherjee, Prativa Mukherjee and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 25 Nov 2022 | ₹1.00 M | Open |
Stte Bank Of India Creation Date: 25 Oct 2010 | ₹2.45 M | Open |
State Bank Of India Creation Date: 27 Nov 2008 | ₹2.40 M | Open |
How Many Employees Work at Bantings Pharmaceuticals?
Unlock and access historical data on people associated with Bantings Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bantings Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bantings Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
